Sustaining Action Against Antimicrobial Resistance: A Case Series of Country Experiences
Antimicrobial resistance (AMR) occurs when microbes, bacteria, viruses, fungi, and parasites, evolve in ways that reduce medicine's ability to fight them. AMR has made many infections, particularly bacterial infections, increasingly difficult or even impossible to treat. Without effective medic...
Gespeichert in:
Körperschaft: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, D.C
The World Bank
2022
|
Schriftenreihe: | Other Health Study
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | Antimicrobial resistance (AMR) occurs when microbes, bacteria, viruses, fungi, and parasites, evolve in ways that reduce medicine's ability to fight them. AMR has made many infections, particularly bacterial infections, increasingly difficult or even impossible to treat. Without effective medicines, the number of people with severe microbial infections will increase, as will the number of people who die from these infections. In 2019, 4.95 million deaths were associated with AMR, with the highest AMR-attributable death rates occurring in western sub-Saharan Africa.8 While AMR is a natural evolutionary process that occurs over time, many human-led behaviors have increased its occurrence. The main drivers of AMR include: (1) the misuse and overuse of antimicrobials; (2) lack of access to clean water and adequate sanitation for people and animals; (3) poor infection prevention and control measures in healthcare facilities and farms; (4) limited access to quality, affordable medicines, vaccines, and diagnostics; and (5) lack of awareness and knowledge about AMR. Additionally, for countries to progress from planning to acting, AMR coordination committees must have a clearly defined role and the remit to develop and implement an operational plan. Operational plans should embed NAP activities into the national development agenda, sectoral strategies, and budgets, and should coordinate an aligned approach to delivering NAP activities across sectors and stakeholders. Creating and empowering AMR coordination committees and comprehensively implementing and monitoring the prioritized activities outlined in their NAPs operational plan takes time; but there are several relatively easy entry points for AMR action that countries can utilize to accelerate their fight against AMR. The remaining case studies in this series showcase successful actions against AMR that three countries, Burkina Faso, Jordan, and Malawi, have taken along their journey to fully operationalizing and implementing their NAPs on AMR |
Beschreibung: | 1 Online-Ressource |
DOI: | 10.1596/38162 |
Internformat
MARC
LEADER | 00000nmm a22000001c 4500 | ||
---|---|---|---|
001 | BV049079737 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 230731s2022 xxu|||| o||u| ||||||eng d | ||
024 | 7 | |a 10.1596/38162 |2 doi | |
035 | |a (ZDB-1-WBA)08354335X | ||
035 | |a (OCoLC)1392150003 | ||
035 | |a (DE-599)KEP08354335X | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a xxu |c XD-US | ||
049 | |a DE-12 |a DE-521 |a DE-573 |a DE-523 |a DE-Re13 |a DE-19 |a DE-355 |a DE-703 |a DE-91 |a DE-706 |a DE-29 |a DE-M347 |a DE-473 |a DE-824 |a DE-20 |a DE-739 |a DE-1043 |a DE-863 |a DE-862 | ||
110 | 2 | |a World Bank Group |e Verfasser |4 aut | |
245 | 1 | 0 | |a Sustaining Action Against Antimicrobial Resistance |b A Case Series of Country Experiences |
264 | 1 | |a Washington, D.C |b The World Bank |c 2022 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Other Health Study | |
520 | 3 | |a Antimicrobial resistance (AMR) occurs when microbes, bacteria, viruses, fungi, and parasites, evolve in ways that reduce medicine's ability to fight them. AMR has made many infections, particularly bacterial infections, increasingly difficult or even impossible to treat. Without effective medicines, the number of people with severe microbial infections will increase, as will the number of people who die from these infections. In 2019, 4.95 million deaths were associated with AMR, with the highest AMR-attributable death rates occurring in western sub-Saharan Africa.8 While AMR is a natural evolutionary process that occurs over time, many human-led behaviors have increased its occurrence. | |
520 | 3 | |a The main drivers of AMR include: (1) the misuse and overuse of antimicrobials; (2) lack of access to clean water and adequate sanitation for people and animals; (3) poor infection prevention and control measures in healthcare facilities and farms; (4) limited access to quality, affordable medicines, vaccines, and diagnostics; and (5) lack of awareness and knowledge about AMR. Additionally, for countries to progress from planning to acting, AMR coordination committees must have a clearly defined role and the remit to develop and implement an operational plan. Operational plans should embed NAP activities into the national development agenda, sectoral strategies, and budgets, and should coordinate an aligned approach to delivering NAP activities across sectors and stakeholders. | |
520 | 3 | |a Creating and empowering AMR coordination committees and comprehensively implementing and monitoring the prioritized activities outlined in their NAPs operational plan takes time; but there are several relatively easy entry points for AMR action that countries can utilize to accelerate their fight against AMR. The remaining case studies in this series showcase successful actions against AMR that three countries, Burkina Faso, Jordan, and Malawi, have taken along their journey to fully operationalizing and implementing their NAPs on AMR | |
650 | 4 | |a Communicable Diseases | |
650 | 4 | |a Disease Control and Prevention | |
650 | 4 | |a Health Policy | |
650 | 4 | |a Health Policy and Management | |
650 | 4 | |a Health, Nutrition and Population | |
650 | 4 | |a Public Health | |
856 | 4 | 0 | |u https://doi.org/10.1596/38162 |x Verlag |z kostenfrei |3 Volltext |
912 | |a ZDB-1-WBA | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-034341628 |
Datensatz im Suchindex
_version_ | 1824556231881129984 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author_corporate | World Bank Group |
author_corporate_role | aut |
author_facet | World Bank Group |
author_sort | World Bank Group |
building | Verbundindex |
bvnumber | BV049079737 |
collection | ZDB-1-WBA |
ctrlnum | (ZDB-1-WBA)08354335X (OCoLC)1392150003 (DE-599)KEP08354335X |
discipline | Wirtschaftswissenschaften |
discipline_str_mv | Wirtschaftswissenschaften |
doi_str_mv | 10.1596/38162 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a22000001c 4500</leader><controlfield tag="001">BV049079737</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230731s2022 xxu|||| o||u| ||||||eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1596/38162</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-1-WBA)08354335X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1392150003</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP08354335X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-523</subfield><subfield code="a">DE-Re13</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-M347</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-1043</subfield><subfield code="a">DE-863</subfield><subfield code="a">DE-862</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">World Bank Group</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sustaining Action Against Antimicrobial Resistance</subfield><subfield code="b">A Case Series of Country Experiences</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C</subfield><subfield code="b">The World Bank</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Other Health Study</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Antimicrobial resistance (AMR) occurs when microbes, bacteria, viruses, fungi, and parasites, evolve in ways that reduce medicine's ability to fight them. AMR has made many infections, particularly bacterial infections, increasingly difficult or even impossible to treat. Without effective medicines, the number of people with severe microbial infections will increase, as will the number of people who die from these infections. In 2019, 4.95 million deaths were associated with AMR, with the highest AMR-attributable death rates occurring in western sub-Saharan Africa.8 While AMR is a natural evolutionary process that occurs over time, many human-led behaviors have increased its occurrence.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">The main drivers of AMR include: (1) the misuse and overuse of antimicrobials; (2) lack of access to clean water and adequate sanitation for people and animals; (3) poor infection prevention and control measures in healthcare facilities and farms; (4) limited access to quality, affordable medicines, vaccines, and diagnostics; and (5) lack of awareness and knowledge about AMR. Additionally, for countries to progress from planning to acting, AMR coordination committees must have a clearly defined role and the remit to develop and implement an operational plan. Operational plans should embed NAP activities into the national development agenda, sectoral strategies, and budgets, and should coordinate an aligned approach to delivering NAP activities across sectors and stakeholders.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Creating and empowering AMR coordination committees and comprehensively implementing and monitoring the prioritized activities outlined in their NAPs operational plan takes time; but there are several relatively easy entry points for AMR action that countries can utilize to accelerate their fight against AMR. The remaining case studies in this series showcase successful actions against AMR that three countries, Burkina Faso, Jordan, and Malawi, have taken along their journey to fully operationalizing and implementing their NAPs on AMR</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Disease Control and Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Policy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Policy and Management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health, Nutrition and Population</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public Health</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1596/38162</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-WBA</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034341628</subfield></datafield></record></collection> |
id | DE-604.BV049079737 |
illustrated | Not Illustrated |
index_date | 2024-07-03T22:27:56Z |
indexdate | 2025-02-20T07:20:17Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034341628 |
oclc_num | 1392150003 |
open_access_boolean | 1 |
owner | DE-12 DE-521 DE-573 DE-523 DE-Re13 DE-BY-UBR DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-91 DE-BY-TUM DE-706 DE-29 DE-M347 DE-473 DE-BY-UBG DE-824 DE-20 DE-739 DE-1043 DE-863 DE-BY-FWS DE-862 DE-BY-FWS |
owner_facet | DE-12 DE-521 DE-573 DE-523 DE-Re13 DE-BY-UBR DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-91 DE-BY-TUM DE-706 DE-29 DE-M347 DE-473 DE-BY-UBG DE-824 DE-20 DE-739 DE-1043 DE-863 DE-BY-FWS DE-862 DE-BY-FWS |
physical | 1 Online-Ressource |
psigel | ZDB-1-WBA |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | The World Bank |
record_format | marc |
series2 | Other Health Study |
spellingShingle | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences Communicable Diseases Disease Control and Prevention Health Policy Health Policy and Management Health, Nutrition and Population Public Health |
title | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences |
title_auth | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences |
title_exact_search | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences |
title_exact_search_txtP | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences |
title_full | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences |
title_fullStr | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences |
title_full_unstemmed | Sustaining Action Against Antimicrobial Resistance A Case Series of Country Experiences |
title_short | Sustaining Action Against Antimicrobial Resistance |
title_sort | sustaining action against antimicrobial resistance a case series of country experiences |
title_sub | A Case Series of Country Experiences |
topic | Communicable Diseases Disease Control and Prevention Health Policy Health Policy and Management Health, Nutrition and Population Public Health |
topic_facet | Communicable Diseases Disease Control and Prevention Health Policy Health Policy and Management Health, Nutrition and Population Public Health |
url | https://doi.org/10.1596/38162 |
work_keys_str_mv | AT worldbankgroup sustainingactionagainstantimicrobialresistanceacaseseriesofcountryexperiences |